Ebstein's anomaly of the tricuspid valve prognosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
__NOTOC__ | __NOTOC__ | ||
'''Associate Editor-In-Chief:''' {{CZ}} | '''Associate Editor-In-Chief:''' {{CZ}} | ||
==Prognosis== | |||
===Adverse prognostic factors are=== | ===Adverse prognostic factors are=== | ||
| Line 15: | Line 17: | ||
e)Paradoxical emboli | e)Paradoxical emboli | ||
==References== | ==References== | ||
Revision as of 19:00, 27 June 2011
|
Ebsteins anomaly of the tricuspid valve Microchapters | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
Ebstein's anomaly of the tricuspid valve prognosis On the Web | |
|
American Roentgen Ray Society Images of Ebstein's anomaly of the tricuspid valve prognosis | |
|
Ebstein's anomaly of the tricuspid valve prognosis in the news | |
|
Risk calculators and risk factors for Ebstein's anomaly of the tricuspid valve prognosis | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] and Claudia P. Hochberg, M.D. [2]
Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [3]
Prognosis
Adverse prognostic factors are
a) NYHA Class III or IV
b) Moderate to severe cardiomegaly
c) Cyanosis or an O2 sat < 90%
d) Disability during infancy
e)Paradoxical emboli
References